Latest News

Wednesday, October 12, 2016 | Movement Disorders, Research and Publications

Parkinson’s Disease Therapeutic Conference to Spotlight New Research and Potential Therapeutic Targets

The Michael J. Fox Foundation’s 10th annual Parkinson’s Disease Therapeutic Conference, set to take place on October 24 in New York City, will bring together experts and specialists in res…

Read the full story

Friday, October 07, 2016 | FDA Approval/Clearance, Movement Disorders

New DBS System for Parkinson’s Disease, Essential Tremor Approved

The deep brain stimulation market will soon be expanding, as the FDA has approved St. Jude Medical’s Infinity system for the treatment Parkinson’s disease and essential tremor. Also approv…

Read the full story

Wednesday, October 05, 2016 | FDA Approval/Clearance, Pain & Headache

FDA Greenlights Spinal Cord Stimulation Therapy for Patients with Chronic Pain

The FDA has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) for patients with chronic pain. According to manufacturer St. Jude Medical, BurstDR helps phys…

Read the full story

Wednesday, September 28, 2016 | FDA Approval/Clearance, Visual & Sensory Disturbances

FDA Clears Handheld TBI Assessment Device

The FDA has cleared BrainScope’s newest device for the assessment of traumatic brain injury (TBI), the Ahead 300. Developed in partnership with the US Department of Defense, the Ahead 300 provid…

Read the full story

Wednesday, September 28, 2016 |

Robin Williams’s Widow Joins ABF Board of Directors, Calls for Increased Funding for Brain Disease

Susan Schneider Williams, the widow of actor/comedian Robin Williams, has been appointed to its Board of Directors of the American Brain Foundation (ABF), a national charity whose mission is to bring …

Read the full story

Thursday, September 22, 2016 | Movement Disorders

WPC 2016: Study Elucidates the Role of Neuroinflammation in Pre-diagnosis Parkinson’s Disease

Anti-inflammatory agents could possibly delay progression to a manifest synucleinopathy in subjects with idiopathic REM sleep behaviour disorder (IRBD), according to new findings presented at the ongo…

Read the full story

Wednesday, September 21, 2016 | Movement Disorders

AANEM 2016: Dysport Found Effective at 2 mL Dilution in Cervical Dystonia

A 12-week study presented at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) suggests that a 2 mL dilution of abobotulinumtoxinA (Dysport, Ipsen) may …

Read the full story

Friday, September 16, 2016 | Phase 3/4 Trials, Research and Publications

ECTRIMS: Six-Year Extension Data Elucidate Benefits of Alemtuzumab in Treating Relapsing MS

New six-year extension data presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) suggest that patients treated with Lemtrada (alemtuzumab, San…

Read the full story

Friday, September 16, 2016 | Personnel/Company News

Epilepsy Foundation Unveils New Report, Social Media Hash Tag for SUDEP Awareness Initiative

The Epilepsy Foundation’s SUDEP Institute issued a expert consensus report as part of its social media campaign to motivate people with epilepsy to reduce their risk of Sudden Unexpected Death i…

Read the full story

Thursday, September 15, 2016 | Personnel/Company News

NIH Awards Neural Analytics $3 Million Grant to Study Portable Brain Monitoring Platform

Neural Analytics Inc. has received a $3 million grant from the National Institutes of Health (NIH) to support a clinical validation study of its portable brain monitoring platform. The grant is suppor…

Read the full story

Thursday, September 15, 2016 | Research and Publications, Biogen

ECTRIMS: Results from DECIDE Trial Affirm Benefits of Zinbryta

A new post-hoc analysis from the pivotal DECIDE study shows that a significantly greater number of people treated with Zinbryta (daclizumab, Biogen/AbbVie) achieved no evidence of disease activity (NE…

Read the full story

Thursday, September 15, 2016 | Research and Publications

ECTRIMS: Adoption of New MRI Criteria May Lead to Earlier Diagnosis

Adopting the new guidelines for the use of MRI in the diagnosis of multiple sclerosis (MS) may lead to earlier diagnosis, according to new findings presented at ECTRIMS. The new guidelines, the r…

Read the full story

Wednesday, September 14, 2016 |

Parkinson’s Disease Foundation Launches Live Seminar Series

The Parkinson's Disease Foundation recently launched its eighth series of PD ExpertBriefings -- six free online seminars which address unmet needs in Parkinson's education. The series o…

Read the full story

Wednesday, September 14, 2016 |

Investigational Low-Dose Fenfluramine Found Effective as Adjunctive Therapy in Dravet Syndrome

Data from a new patient cohort in an ongoing open-label study suggests that an investigational low-dose fenfluramine liquid solution may offer benefit as an adjunctive therapy for seizures associated …

Read the full story

Wednesday, September 07, 2016 | Research and Publications

Vaccine against Alpha-Synuclein Increases Immune Response in Parkinson’s Disease in Phase I Study

Results from a Phase I clinical trial suggest that boost immunizations with AFFITOPE® PD01A (AFFiRiS), an active vaccine against a protein that’s thought to play a role in Parkinson´s …

Read the full story
Load More